Construction and Use of Retroviral Vectors Encoding the Toxic Gene Barnase

Molecular Therapy

Volumn 14, Issue 4, 2006, Pages 555-563

  Agarwal, Sumit ^a   Nikolai, Bryan ^a   Yamaguchi, Tomoyuki ^a   Lech, Patrycja ^a   Somia, Nikunj V ^a  

^a Institute of Human Genetics   (United States)

Author keywords

barnase; cell mutants; mutagenesis; negative selection; retroviral vectors; suicide vectors

Indexed keywords

BARNASE; ENZYME INHIBITOR; PENICILLIN G; RETROVIRUS VECTOR; RIBONUCLEASE; STREPTOMYCIN; VIRUS VECTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACILLUS AMYLOLIQUEFACIENS; CELL ISOLATION; CELL MUTANT; CELL SELECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE THERAPY; GENETIC SCREENING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; INFECTION RESISTANCE; MAMMAL CELL; MURINE LEUKEMIA VIRUS; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; SOMATIC CELL GENETICS; SUICIDE GENE THERAPY; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CRICETINAE; GENETIC VECTORS; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; MALE; MUTATION; RIBONUCLEASES; TRANSCRIPTION, GENETIC;

BACILLUS AMYLOLIQUEFACIENS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; MURINE LEUKEMIA VIRUS;

EID: 33748073127     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.03.025     Document Type: Article

References (39)

1. Somia N., and Verma I.M. Gene therapy: trials and tribulations. Nat. Rev., Genet. 1 (2000) 91-99
2. Somia N.V., Schmitt M.J., Vetter D.E., Van Antwerp D., Heinemann S.F., and Verma I.M. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc. Natl. Acad. Sci. USA 96 (1999) 12667-12672
3. Wolkowicz R., and Nolan G.P. Retroviral technology-applications for expressed peptide libraries. Front. Biosci. 8 (2003) d603-d619
4. Mullen C.A., Kilstrup M., and Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA 89 (1992) 33-37
5. van Dillen I.J., Mulder N.H., Vaalburg W., de Vries E.F., and Hospers G.A. Influence of the bystander effect on HSV-tk/GCV gene therapy: a review. Curr. Gene Ther. 2 (2002) 307-322
6. Degreve B., De Clercq E., and Balzarini J. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and ganciclovir (GCV). Gene Ther. 7 (2000) 1543-1552
7. Kurdow R., et al. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC. Anticancer Res. 24 (2004) 827-831
8. Adachi M., et al. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J. Biol. Chem. 277 (2002) 38998-39004
9. Yu D., Chen D., Chiu C., Razmazma B., Chow Y.H., and Pang S. Prostate-specific targeting using PSA promoter-based lentiviral vectors. Cancer Gene Ther. 8 (2001) 628-635
10. Qiao J., and Caruso M. PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells. J. Virol. 76 (2002) 7343-7348
11. Brinkmann U., Brinkmann E., and Pastan I. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins. Mol. Med. 1 (1995) 206-216
12. Foley B.T., Moehring J.M., and Moehring T.J. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A: genetic and biochemical analyses. J. Biol. Chem. 270 (1995) 23218-23225
13. Ciuffi A., et al. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J. Virol. 78 (2004) 10747-10754
14. Naif H.M., et al. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J. Virol. 73 (1999) 4866-4881
15. Hartley R.W. Barnase and barstar: expression of its cloned inhibitor permits expression of a cloned ribonuclease. J. Mol. Biol. 202 (1988) 913-915
16. Silverman R.H. Implications for RNase L in prostate cancer biology. Biochemistry 42 (2003) 1805-1812
17. Mariani C., Goldberg R.B., and Leemans J. Engineered male sterility in plants. Symp. Soc. Exp. Biol. 45 (1991) 271-279
18. Leuchtenberger S., Perz A., Gatz C., and Bartsch J.W. Conditional cell ablation by stringent tetracycline-dependent regulation of barnase in mammalian cells. Nucleic Acids Res. 29 (2001) E76
19. Miyoshi H., Blomer U., Takahashi M., Gage F.H., and Verma I.M. Development of a self-inactivating lentivirus vector. J. Virol. 72 (1998) 8150-8157
20. Follenzi A., Ailles L.E., Bakovic S., Geuna M., and Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25 (2000) 217-222
21. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., and Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101 (2000) 173-185
22. Kim D.W., Uetsuki T., Kaziro Y., Yamaguchi N., and Sugano S. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91 (1990) 217-223
23. Dranoff G., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90 (1993) 3539-3543
24. Naviaux R.K., Costanzi E., Haas M., and Verma I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70 (1996) 5701-5705
25. Eaton D.L., et al. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 25 (1986) 8343-8347
26. Roe T., Reynolds T.C., Yu G., and Brown P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12 (1993) 2099-2108
27. Arai T., Takada M., Ui M., and Iba H. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Virology 260 (1999) 109-115
28. Chu E.H., Brimer P., Jacobson K.B., and Merriam E.V. Mammalian cell genetics. I. Selection and characterization of mutations auxotrophic for l-glutamine or resistant to 8-azaguanine in Chinese hamster cells in vitro. Genetics 62 (1969) 359-377
29. Thacker J. The chromosomes of a V79 Chinese hamster line and a mutant subline lacking HPRT activity. Cytogenet. Cell Genet. 29 (1981) 16-25
30. Taft S.A., Liber H.L., and Skopek T.R. Mutational spectrum of ICR-191 at the hprt locus in human lymphoblastoid cells. Environ. Mol. Mutagen. 23 (1994) 96-100
31. Colella C.M., et al. A genetic analysis of the adenine phosphoribosyl transferase locus in Chinese hamster V79-AP4 cells: relevance to mutagenesis studies. Mutat. Res. 202 (1988) 185-192
32. Kafri T. Gene delivery by lentivirus vectors: an overview. Methods Mol. Biol. 246 (2004) 367-390
33. Thompson L.H. Somatic cell genetics approach to dissecting mammalian DNA repair. Environ. Mol. Mutagen. 14 (1989) 264-281
34. Goff S.P. Retrovirus restriction factors. Mol. Cell 16 (2004) 849-859
35. Gao G., and Goff S.P. Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection. Mol. Biol. Cell 10 (1999) 1705-1717
36. Bruce J.W., Bradley K.A., Ahlquist P., and Young J.A. Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. J. Virol. 79 (2005) 12969-12978
37. Naldini L., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
38. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987) 2745-2752
39. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 (1990) 213-222